BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 53 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -53.8% | 49,635 | 0.0% | 0.00% | – |
| Q2 2022 | $26,000 | -89.2% | 49,635 | -57.4% | 0.00% | – |
| Q1 2022 | $240,000 | -50.7% | 116,592 | -0.2% | 0.00% | – |
| Q4 2021 | $487,000 | -38.1% | 116,838 | +38.0% | 0.00% | – |
| Q3 2021 | $787,000 | -39.1% | 84,668 | +18.0% | 0.00% | – |
| Q2 2021 | $1,292,000 | – | 71,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |